✦ LIBER ✦

The role of opioid receptor agonists and antagonists in the treatment of Parkinson’s disease

✍ Scribed by I. G. Silkis

Book ID: 111470520
Publisher: SP MAIK Nauka/Interperiodica
Year: 2007
Tongue: English
Weight: 473 KB
Volume: 1
Category: Article
ISSN: 1819-7124
DOI: 10.1134/s1819712407040034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Agonist Paradox: Agonists and Antago

The Agonist Paradox: Agonists and Antagonists of Acetylcholine Receptors and Opioid Receptors

✍ Felix S. Dukhovich; Michael B. Darkhovskii; Elena N. Gorbatova; Victor S. Polyak 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

The role of opioid receptor antagonists

The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review

✍ Wojciech Leppert 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 335 KB

Dopamine receptor agonists in the therap

Dopamine receptor agonists in the therapy of Parkinson’s disease

✍ P. Foley; M. Gerlach; K. L. Double; P. Riederer 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 424 KB

Use of the dopamine receptor agonist Mir

Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson’s disease

✍ N. V. Fedorova; I. P. Chigir’ 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 144 KB

Parkinson’s disease: The proper use of d

Parkinson’s disease: The proper use of dopamine receptor agonists

✍ Lisa M. Shulman 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 195 KB

Efficacy of memantine, an NMDA receptor

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease

✍ J. M. Rabey; P. Nissipeanu; A. D. Korczyn 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 363 KB